Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Advanced Therapies
100.0
%
| 329 | 100.0 % | 399 | 100.0 % | +21.30% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Non-United States
63.2
%
| 213 | 64.8 % | 252 | 63.2 % | +18.35% |
United States
36.8
%
| 116 | 35.2 % | 147 | 36.8 % | +26.73% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Bradley Campbell
CEO | Chief Executive Officer | 48 | 06-03-31 |
Simon Harford
DFI | Director of Finance/CFO | 64 | 23-08-20 |
Pat O’Sullivan
COO | Chief Operating Officer | - | 22-06-30 |
Mitchell Goldman
CTO | Chief Tech/Sci/R&D Officer | - | 19-12-31 |
Jill Weimer
CTO | Chief Tech/Sci/R&D Officer | - | 19-06-12 |
Patrik Florencio
CMP | Compliance Officer | - | 15-07-31 |
Andrew Faughnan
IRC | Investor Relations Contact | - | - |
Stephen Arnold
PRN | Corporate Officer/Principal | - | Oct. 31 |
David Clark
HRO | Human Resources Officer | 49 | 18-09-30 |
Samantha Prout
AUD | Comptroller/Controller/Auditor | 46 | 18-02-28 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Bradley Campbell
CEO | Chief Executive Officer | 48 | 06-03-31 |
Lynn Bleil
BRD | Director/Board Member | 60 | 18-09-10 |
Burke W. Whitman
BRD | Director/Board Member | 68 | 19-06-26 |
Margaret McGlynn
BRD | Director/Board Member | 64 | 09-09-30 |
Michael Kelly
BRD | Director/Board Member | 67 | 20-11-30 |
Glenn Sblendorio
BRD | Director/Board Member | 68 | 06-05-31 |
Craig Wheeler
BRD | Director/Board Member | 63 | 16-06-09 |
Mike Raab Raab
CHM | Chairman | 59 | 03-12-31 |
Eiry Roberts
BRD | Director/Board Member | 60 | 21-06-09 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 295,382,614 | 265,100,314 ( 89.75 %) | 0 | 89.75 % |
Company contact information
Sector
Sales per region
1st Jan change | Capi. | |
---|---|---|
+4.09% | 43.43B | |
+47.81% | 41.69B | |
+9.45% | 41.31B | |
-10.92% | 27.14B | |
+9.32% | 25.28B | |
-24.87% | 18.47B | |
+29.70% | 12.59B | |
+1.28% | 12.33B | |
+7.78% | 11.03B |